Market Overview

The global enteral feeding devices market size was valued at USD 4.2 Billion in 2024 and is projected to reach USD 6.8 Billion by 2033, growing at a CAGR of 5.38% during the forecast period 2025-2033. These devices are used to deliver nutrients directly to the digestive tract, predominantly for patients with difficulties in oral intake. Growth is driven by increasing chronic diseases, a rising geriatric population, technological advancements, and expanding home enteral nutrition markets.

Study Assumption Years

• Base Year: 2024

• Historical Year/Period: 2019-2024

• Forecast Year/Period: 2025-2033

Enteral Feeding Devices Market Key Takeaways

• Current Market Size: USD 4.2 Billion in 2024

• CAGR: 5.38% during 2025-2033

• Forecast Period: 2025-2033

• Enteral feeding devices help deliver nutrients directly into the digestive tract for patients with oral intake challenges.

• The market is largely driven by rising prevalence of chronic diseases like diabetes, cancer, and gastrointestinal disorders.

• An increasing geriatric population vulnerable to such illnesses is fueling market demand.

• Technological advances such as flexible silicon-based feeding tubes and low-profile gastrostomy buttons support market expansion.

• The growing adoption of home enteral nutrition positively impacts market growth.

Sample Request Link: https://www.imarcgroup.com/enteral-feeding-devices-market/requestsample

Market Growth Factors

The global enteral feeding devices market is propelled by a significant rise in chronic diseases including diabetes, cancer, and gastrointestinal ailments. Such diseases impair traditional oral intake methods, necessitating the use of feeding devices to deliver essential nutrients safely and consistently. By 2024, the market was valued at USD 4.2 Billion, highlighting the critical healthcare need that these devices fulfill. This sustained demand is expected to increase with an ageing global population, which is more susceptible to these medical conditions. The elderly demographic often suffers from neurological disorders such as multiple sclerosis, stroke, and dementia, which weaken swallowing abilities and cause malnourishment, further escalating the demand for enteral feeding devices.

Increased geriatric populations worldwide are particularly vulnerable to chronic illnesses, intensifying the market opportunity for enteral feeding solutions. The rising proportion of elderly individuals who require specialized nutritional support fuels the need for patient-friendly and efficient devices. Additionally, advancements in enteral feeding technology have enhanced the usability and safety of these products. For instance, newer silicon-based feeding tubes are more flexible and cause less irritation compared to traditional polyvinylchloride tubes. Moreover, innovations such as low-profile gastrostomy buttons suitable for both pediatric and adult patients improve patient comfort and device adaptability, fostering greater market acceptance.

The burgeoning trend of home enteral nutrition, where patients receive nutritional support outside hospital settings, is contributing to optimistic market prospects. Home healthcare advancements and enhanced healthcare infrastructure support increased accessibility and adoption of enteral feeding devices. Hospitals, ambulatory surgery centers, and other healthcare facilities are progressively integrating these devices to meet the nutritional requirements of patients post-surgery or in critical care. Alongside this, the demand for specialized devices for neonatal and preterm patients is rising, aided by technological progress and growing awareness among caregivers. These factors collectively strengthen the enteral feeding devices market trajectory towards a forecast size of USD 6.8 Billion by 2033.

Market Segmentation

IMARC Group categorizes the global enteral feeding devices market by product type, age group, application, and end user, providing detailed trends and forecasts at the global and regional levels for 2025-2033.

Product Type:

• Enteral Feeding Pumps: Automated devices that deliver nutrition at controlled rates.

• Enteral Feeding Tubes: Tubes inserted into the digestive tract for nutrient delivery.

• Giving Sets: Tubing sets connecting feeding devices to feeding tubes.

• Enteral Syringes: Devices used to manually feed or administer medication.

• Consumables: Single-use items necessary for enteral feeding.

• Others: Additional accessory devices related to enteral feeding.

Age Group:

• Adults: Patients aged 18 and above requiring enteral feeding support.

• Pediatrics: Infant and child patients utilizing enteral feeding devices.

Application:

• Oncology: Usage for cancer patients needing nutritional support.

• Gastroenterology: Devices used for digestive system-related conditions.

• Neurology: Applications involving neurological illnesses affecting feeding.

• Diabetes: Feeding devices assisting diabetic patients.

• Hypermetabolism: Nutritional support for patients with increased metabolic demands.

• Others: Additional medical conditions requiring enteral feeding.

End User:

• Hospitals: Healthcare institutions using enteral feeding devices.

• Ambulatory Surgery Centers: Outpatient surgery facilities employing these devices.

• Others: Other healthcare or care settings utilizing enteral feeding devices.

Regional Insights

North America is identified as a dominant region in the enteral feeding devices market, supported by advanced healthcare infrastructure and widespread adoption of innovative feeding technologies. The region includes the United States and Canada, which contribute significantly to the global market share. Other key regions covered in the report are Asia Pacific, Europe, Latin America, and the Middle East and Africa. The growing geriatric population, rising chronic disease prevalence, and increasing investment in home healthcare in North America are factors driving market growth.

Key Players

• Abbott Laboratories

• Amsino International Inc.

• B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG)

• BD (Becton Dickinson and Company)

• Boston Scientific Corporation

• Cardinal Health Inc.

• Conmed Corporation

• Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)

• Moog Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Get insights that fit your strategy — Request your customized version now!

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302